IN8BIO, INC. — Director's Dealing 2021

Aug 3, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: IN8BIO, INC. (INAB)
CIK: 0001740279
Period of Report: 2021-07-29

Reporting Person: McCall Patrick (Chief Financial Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-07-29	Employee Stock Option (right to buy)	$10.00	A	40000	Acquired	2031-07-29	Common Stock (40000)	Direct

Footnotes

F1: One forty-eighth (1/48th) of the shares subject to the option shall vest in equal monthly installments commencing on August 29, 2021, subject to the Reporting Person continuing to provide service through each such date.